1. Quantitation of c-erbB-2 Gene Amplification in Breast Cancer Tissue by Competitive PCR
- Author
-
Keigo Takagi, Shuichi Sasamoto, Hiroyuki Shimatake, Nobuo Okuyama, S. Yamazaki, Maki Yanagida, Nobuhide Katou, Yoshinori Hatano, Shinji Shimatani, Hiromichi Hemmi, Akira Inoue, Youngjin Park, and Myouta Miura
- Subjects
Univariate analysis ,Pathology ,medicine.medical_specialty ,Oncogene ,Mammary gland ,Estrogen receptor ,General Medicine ,Biology ,medicine.disease ,medicine.anatomical_structure ,Breast cancer ,medicine ,Cancer research ,Lymphatic vessel ,Carcinoma ,Lymph node - Abstract
Controversy exists regarding the relationship of the degree of c-erbB-2 amplification to other prognostic factors in breast cancer. To determine the degree of amplification of c-erbB-2 exactly, a sensitive and quantitative method is required. We have developed a competitive PCR method to quantitatively determine the amplification of the c-erbB-2 oncogene. Using this method, we evaluated DNA from 27 breast cancer tissue specimens and DNA from peripheral blood leukocytes from a normal individual. Regarding the relationship between the degree of c-erbB-2 amplification and clinicopathological factors, we found a greater degree of amplification of the c-erbB-2 oncogene in estrogen receptor- negative or progesterone receptor-negative specimens than in positive ones and in lymph node metastasis-positive specimens than in negative specimens, in stages II, III, and IV of disease compared with stage I disease, and in samples with positive lymphatic vessel invasion than with no lymphatic vessel invasion. Generally, these factors were seen in the group of patients who had a bad prognosis. By univariate analysis and multivariate analysis, reverse correlation was observed between amplification of c-erbB-2 and overall survival. Regarding disease-free survival, these relationships were observed only with univariate analysis in our group of patients.
- Published
- 1999
- Full Text
- View/download PDF